Sleep Disorders

Abstract

<P>This issue on sleep disorders began in the late 1990s when Paul Casola, MD, PhD, FRCPC, and I began to look at sleeping problems in the dual diagnosis population as part of a small study group. At that time, it seemed that such problems were ubiquitous and not talked about. The combination made it the perfect focus. We were not trained in sleep pathology and began from ground zero in knowledge.</P> <H4>ABOUT THE GUEST EDITOR</H4> <P>R. Jeffrey Goldsmith, MD, has been on the faculty of the Department of Psychiatry, University of Cincinnati College of Medicine, since 1981. He is board certified in psychiatry, has a CAQ in addiction psychiatry, and was certified by the American Society of Addiction Medicine in 1986.</P> <P>Dr. Goldsmith serves as Professor of Clinical Psychiatry, Director of Addiction Fellowships, and staff psychiatrist at the VA Medical Center Dual Diagnosis Clinic. He has been at the VAMC since 1983, and recently finished 11 years with the Cincinnati Addiction Research Center as part of the National Institute on Drug Abuse’s Clinical Trials Network, Medication Development Research Unit, and Clinical Trials Organization. He worked as co-investigator and principal investigator for a number of their clinical trials, including the buprenorphine/naloxone study, the pivotal study for Food and Drug Administration approval of buprenorphine for opiate dependence. </P><P>For 13 years, he was clinical director for Crossroads Center, a freestanding outpatient program that included culturally-specific treatment programs for African Americans with substance dependence problems. He supervised staff, worked with probation and other community organizations, ran the dual diagnosis division, worked with high-risk teen projects, and consulted with their African American women’s residential project. </P><P>Dr. Goldsmith has published more than 50 chapters and papers. He also developed an ACGME-accredited Addiction Psychiatry fellowship and a VA-funded Addiction Medicine Fellowship. </P><P>Dr. Goldsmith has been chair of the ASAM Continuing Medical Education Committee for the past 6 years. He was also program chair for the past two Nicotine Dependence Conferences and served on the Med-Sci Program Committee for the past 4 years. He is on the current Publications Task Force, and was recently appointed to the Editorial Board of the <cite>Journal of Addictive Diseases</cite>. </P><P>Dr. Goldsmith is a founding member of American Academy of Addiction Psychiatry, and is on the board of the Cincinnati Psychoanalytic Institute in Ohio.</P>